UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Why Track A Financial Index explains the value of benchmarks for performance evaluation, risk management, and strategy alignment.
24,485 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Boeing stands at greater risk than peers if Elon Musk's Tesla and SpaceX ever join forces, a scenario analysts say co...
As Q2 2026 gains momentum, XRP, Solana, and BNB post modest climbs. Investors eye price thresholds and upcoming catal...
Memory names bounced Thursday, with SanDisk up 9%, Western Digital rising 5%, and Micron gaining 3% as AI-driven stor...
SEA’s December 2025 payout fell 60% from 2024, exposing how its dividend is tied to cyclical freight profits rather t...
Vitalik Buterin announced a recalibration of the Ethereum Foundation's role, underscoring a shift toward a smaller, p...
A narrow, theme-driven ETF focused on generative AI shows mixed results as broader AI funds rally. The concentrated a...
Shares surged after quarterly results, lifting the outlook for this dividend-paying chip stock. Analysts say the stoc...
A new leave-planning method is turning a modest PTO bank into long, strategic breaks. The so-called 'pto-maxxing' sum...
Micron crosses a $1 trillion market cap as AI memory demand surges. Here’s what investors should watch for in 2026.
XRP-linked ETFs attracted $1.77 million in new money, lifting total XRP ETF assets to about $1.12 billion, even as th...
American Express trades around $315 as Q1 2026 results highlight growth in card member spending and improving credit ...